Ligand Pharmaceuticals Inc (LGNZZ)

Pharmaceutical Preparations

Latest Price

TTM P/E

Normalized P/E

TTM Div Yield

Fwd Div Yield

Book Value

P/B Ratio

Valuation metrics

EPS: $6.13

Book value / share: $51.44

Formula: √(22.5 × EPS × BVPS)

Graham Number

$84.23

Norm. op. income: $26M (median of 7yr)

Tax rate: 21%

Discount rate: 10%

Growth assumption: zero (EPV is a no-growth value)

Earnings Power Value

$47.42

Base FCF: $70M (median of recent 5yr)

Growth: 25%/yr (median YOY, capped at 25%)

Discount rate: 10%

Terminal growth: 3%

Projection horizon: 10 years

DCF Fair Value

$300.69

EPS: $6.13

Target P/E: 15×

Formula: EPS × P/E

P/E Fair Value

$91.95